SEC Info - Asterias Biotherapeutics, Inc. - ‘S-3’ on 5/26/15

SEC Info℠

Home

Help

Please Sign In

Asterias Biotherapeutics, Inc. – ‘S-3’ on 5/26/15 – EX-23.2

On: Tuesday, 5/26/15, at 6:39am ET · Accession #: 1140361-15-21660 · File #: 333-204441

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 5/26/15  Asterias Biotherapeutics, Inc.    S-3                    4:343K                                   Summit Fin’l Printing

Registration Statement for Securities Offered Pursuant to a Transaction — Form S-3
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-3         Asterias Biotherapeutics, Inc. S-3 5-26-2015        HTML    132K 
 2: EX-5.1      Opinion re: Legality                                HTML     11K 
 3: EX-23.1     Consent of Experts or Counsel                       HTML      5K 
 4: EX-23.2     Consent of Experts or Counsel                       HTML      5K

EX-23.2 — Consent of Experts or Counsel

This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

Exhibit 23.2

Consent of Independent Registered Public Accounting Firm

We hereby consent to the incorporation by reference in the Registration Statement of Asterias Biotherapeutics, Inc. (the “Company”) on Form S-3 of our report dated March 17, 2014, with respect to the financial statements of the Company for the year ended December 31, 2013 and for the period from September 24, 2012 (inception) to December 31, 2012, which report appears in the Annual Report on Form 10-K of the Company for the year ended December 31, 2014.

/s/ Rothstein Kass

New York, New York

May 21, 2015

Dates Referenced Herein and Documents Incorporated by Reference

This ‘S-3’ Filing	Date	Other Filings

Filed on:	5/26/15
	5/21/15
	12/31/14	10-K, 10-K/A
	3/17/14	10-K
	12/31/13	10-K
	12/31/12
	9/24/12
		List all Filings

1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/03/15  SEC                               UPLOAD¶    10/03/17    1:150K Asterias Biotherapeutics, Inc.

↑Top

Filing Submission 0001140361-15-021660 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)